載入...
Pilot Study of Oral Valganciclovir Therapy in Patients With Classic Kaposi Sarcoma
We conducted a clinical trial of oral valganciclovir, a drug with in vitro activity against Kaposi sarcoma (KS)–associated herpesvirus (KSHV), in classic KS. Five human immunodeficiency virus–seronegative participants received valganciclovir for up to six 4-week cycles at doses used for cytomegalovi...
Na minha lista:
| 發表在: | J Infect Dis |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6767870/ https://ncbi.nlm.nih.gov/pubmed/21450998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiq177 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|